European Medicines Agency gives green light for Oxford-AstraZeneca Vaccine

Oxford-AstraZeneca Vaccine | Photo: NBC

London, UK – European Medicine Agency (EMA) has concluded that the Oxford-AstraZeneca vaccine is safe, which has resulted in the continuation of the vaccine programs.

Due to the growing concerns of blood clotting after getting vaccinated with Oxford-AstraZeneca, 20 countries including Germany and France had stopped their vaccination programs.

A team in Norway that researched the aftereffects of Oxford-AstraZeneca vaccine figured out why it leads to blood clotting. They have said that it is due to the immune response that occurs, to fight the foreign bodies in the vaccine.

We have concluded that this is the reason why the blood clotting process occurs. This also happened to our employees after they got vaccinated.

Professor Paul Andre, Chief Physicist

The blood clotting occurred in 3 people in Norway following their vaccination and had to be hospitalized due to it. Reports said that they had blood clots all over their body including the brain and the stomach. Unfortunately, one of them died due to extreme nosebleeds and vomiting of blood.

Norway has said that they are trying to find a solution by working with related associations. They have also added that this is just because of the way the vaccines work and that scientists are figuring it out in the meantime.

Oxford-AstraZeneca vaccine is given worldwide. Even in Norway, over 120,000 people have been vaccinated with it. About 17 million people over the world have been given Oxford-AstraZeneca shots.